Profound Medical Corp.

Stage 4 · Declining · week 5

As of Oct 22, 2026, Profound Medical is in Stage 4, the downtrend phase, now in week 5 (since Sep 21, 2026). It closed at $5.76, 33.4% below its 52-week high and below its 200-day average, which is falling.

$5.76

+1.23% today

$210M · Micro cap

Market Neutral — Building

Pro read

Pro

Our read

Declining, below its long-term trend

Setup score

—

Momentum

Accelerating ⇈

Edge

—

Is PROF early, or has it already run? Pro answers that for every US stock we cover, after every close.

Get Pro · $19 a month

Renews monthly until you cancel. Cancel any time in Plan & billing.

Loading price chart…

Stage Cycle Timeline2023-08-16 → 2026-10-22

S4 36w

S2 15w

S2 17w

2023-08-162026-10-22

S1S2S3S4Setup score (0–10, dashed line at 5)

S3 3w → S4 10w → S1 6w → S4 12w → S1 3w → S4 10w → S1 4w → S2 8w → S3 4w → S4 36w → S1 8w → S4 9w → S1 4w → S2 15w → S3 11w → S2 17w → S3 1w → S4 5w current

Total tracked: 165 weeks across 18 stage runs.

PROF among Medical Devices49th of 141 by relative strength

All 141 →

Stocks in Medical Devices ranked by relative strength, with stage and one-month change
#	Stock	Stage	RS	1M
1	TXG10x Genomics, Inc.	Stage 2 · wk 48	99	−7.8%
2	RCELAvita Medical, Inc.	Stage 2 · wk 13	98	+40.8%
3	BFLYButterfly Network, Inc. Class A	Stage 2 · wk 26	98	−26.0%
4	HAEHaemonetics Corporation	Stage 2 · wk 17	96	+8.7%
5	GKOSGlaukos Corporation	Stage 2 · wk 25	96	+15.1%
6	AXGNAxogen, Inc.	Stage 3 · wk 2	95	−15.3%
7	NEOGNeogen Corporation	Stage 2 · wk 14	95	−11.7%
8	BVSBioventus Inc. Class A	Stage 2 · wk 15	95	+10.5%
…49	PROFProfound Medical Corp.	Stage 4 · wk 5	52	+0.4%

vs 52W High

-33.4%

$5.06 lo$8.65 hi

33.4% below 52W high, ongoing decline

In Stage 4, distance from the 52-week high reflects an ongoing decline, not a discount.

Stage Maturity

Week 5

1w13w26w

Week 5, early Stage 4 decline

How long this stock has been in Stage 4 decline. The longer the downtrend, the more entrenched the selling pressure. No length of decline marks a bottom on its own.

vs 200 DMA

-14.6%

200 DMA: $6.75 · sloping down

In Stage 4, the stock is below its 200-day average, the hallmark of a downtrend. Stage analysis waits for that to reverse before buying.

Rel Volume

1.69x

vs 50-day avg

High volume on down days in Stage 4 confirms institutional selling. Low-volume bounces are typical. They lack real buyers and are easy to mistake for reversals.

Trend Health

↑ ⇈

Short-term trend rising strongly, and accelerating

Two reads of momentum. The arrow shows the direction of the short-term trend: rising (↑ or ↗), flat (→) or rolling over (↓). The ⇈ mark appears when our trend model reads the move as gaining speed on top of the longer trend. Strongest when both agree.

+0.4%

-20.7%

-14.7%

YTD

-24.8%

-1.7%

Scan Membership

Breakout Watch

Latest: 2024-07-25

5 appearances in last 60 days. First seen: 2020-08-13.

A stock that keeps qualifying week after week does so because its Stage 2 structure keeps holding. Staying power in the scan says more about the trend than any single appearance.

Recent Stage Timeline

2026-10-22S4

Wk 5 · Vol 1.69x

2026-10-21S4

Wk 5 · Vol 0.40x

2026-10-20S4

Wk 5 · Vol 0.54x

2026-10-19S4

Wk 5 · Vol 0.61x

2026-10-16S4

Wk 4 · Vol 0.65x

2026-10-15S4

Wk 4 · Vol 0.87x

2026-10-14S4

Wk 4 · Vol 1.32x

2026-10-13S4

Wk 4 · Vol 1.92x

2026-10-12S4

Wk 4 · Vol 1.59x

2026-10-09S4

Wk 3 · Vol 2.32x

2026-10-08S4

Wk 3 · Vol 23.47x

2026-10-07S4

Wk 3 · Vol 3.28x

Moving averages & range

50 DMA

$6.34

200 DMA

$6.75

52W High

$8.65

52W Low

$5.06

5D Low

$5.69

Resistance levels (recent highs)

20d High

$7.25

60d High

$8.36

120d High

$8.36

250d High

$8.65

Next resistance

+25.9%

to 20d High

ROE

-73.5%

Profit margin -171.6%

Dividend Yield

0.00%

P/B 4.2

Profound Medical: quick answers

What stage is Profound Medical in?

As of Oct 22, 2026, Profound Medical (PROF) is in Stage 4, the downtrend phase. It entered Stage 4 on Sep 21, 2026 and is in week 5. What the four stages mean

Is Profound Medical in an uptrend?

No. Profound Medical is in a Stage 4 downtrend. It trades 14.6% below its 200-day average, which is falling.

How far is Profound Medical from its 52-week high?

Profound Medical closed at $5.76 on Oct 22, 2026, 33.4% below its 52-week high of $8.65. Its 52-week low is $5.06.

How has Profound Medical performed over the past year?

As of Oct 22, 2026, Profound Medical is down 1.7% over the past year and down 24.8% so far in 2026.

Which sector and industry is Profound Medical in?

Profound Medical is in the Medical Devices industry, part of the Health Care sector.

About this companyHealth Care· Medical Devices

Profound Medical Corp. operates as a commercial-stage medical device company that develops and markets AI-powered, MRI-guided, incision-free therapeutic systems for the image guided ablation of diseased tissue. The company's lead product TULSA-PRO system combines magnetic resonance imaging (MRI), robotically driven transurethral sweeping action/thermal ultrasound and closed-loop temperature feedback control to ablate whole gland or physician defined region of malignant or benign prostate tissue. It also provides Sonalleve, which combines real-time MRI and thermometry for the treatment of uterine fibroids, adenomyotic tissue, palliative pain treatment of bone metastases, osteoid osteoma, and management of benign tumors. It operates in Canada, Germany, the United States, China, and Finland. Profound Medical Corp. is headquartered in Mississauga, Canada.

Visit company website →

All analytics based on EOD data. Data as of 2026-10-22. Past data patterns are not indicative of future results. This page is a data analytics tool only.